Synthesis of New 6-[4-(2-Fluorophenylpiperazine-1-YL)]-3(2H)-Pyridazinone-2-Acethyl-2- (Substitutedbenzal)Hydrazone Derivatives and Evulation of Their Cytotoxic Effects in Liver and Colon Cancer Cell Lines
- Authors: Özdemir Z.1, Başak-Türkmen N.2, Ayhan İ.3, Çiftçi O.4, Uysal M.5
- 
							Affiliations: 
							- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Inonu University
- Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Inonu University
- Department of Medical Pharmacology, Faculty of Medicine, Yıldırım Beyazıt University
- Department of Medical Pharmacology, Faculty of Medicine, Pamukkale University
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University
 
- Issue: Vol 52, No 11 (2019)
- Pages: 923-929
- Section: Article
- URL: https://ogarev-online.ru/0091-150X/article/view/245539
- DOI: https://doi.org/10.1007/s11094-019-01927-y
- ID: 245539
Cite item
Abstract
In this study, seven new 3(2H)-pyridazinone derivatives expected to show cytotoxic activity in liver and colon cancer cell lines were synthesized. Their structures were confirmed by the IR, 1H-NMR, 13C-NMR spectra and elementary analyses. Compunds V1-V7 were tested on HEP3B (liver cancer) and HTC116 (colon cancer) cell lines for cytotoxicity by using MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)- 2H-tetrazolium] proliferation assay. Human fibroblast cells were used as safety control in these tests. 6-[4-(2-Fluorophenyl)piperazine-1-yl]-3(2H)-pyridazinone-2-acetyl-2-(2-chlorobenzal)hydrazone (compound V3 ) was the most active agent with respect to HEP3B and HTC116 cell lines.
Keywords
About the authors
Zeynep Özdemir
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Inonu University
							Author for correspondence.
							Email: zeynep.bulut@inonu.edu.tr
				                					                																			                												                	Turkey, 							Malatya, 44280						
Neşe Başak-Türkmen
Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Inonu University
														Email: zeynep.bulut@inonu.edu.tr
				                					                																			                												                	Turkey, 							Malatya, 44280						
İdris Ayhan
Department of Medical Pharmacology, Faculty of Medicine, Yıldırım Beyazıt University
														Email: zeynep.bulut@inonu.edu.tr
				                					                																			                												                	Turkey, 							Ankara, 06100						
Osman Çiftçi
Department of Medical Pharmacology, Faculty of Medicine, Pamukkale University
														Email: zeynep.bulut@inonu.edu.tr
				                					                																			                												                	Turkey, 							Denizli, 20160						
Mehtap Uysal
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Gazi University
														Email: zeynep.bulut@inonu.edu.tr
				                					                																			                												                	Turkey, 							Ankara, 06100						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					